Jade Biosciences Cash Flow Statement (2020-2026) | JBIO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-5.78M	-6.18M	-8.22M	-10.91M	-11.99M	-13.59M	27.49M	-16.52M	-19.02M	-19.56M	45.22M	-23.19M	-0.60M	-14.58M	-46.98M	-38.17M	-25.95M	-25.15M	-31.89M	-40.37M
Depreciation and Depletion (Quarter)	0.00M	0.00M	0.01M	0.01M	0.02M	0.02M	0.02M	0.02M	0.02M	0.03M	0.03M	0.03M	0.03M	0.22M	0.01M	0.00M	0.00M	0.01M	0.01M	0.01M
Share-based Compensation (Quarter)	0.32M	0.84M	0.85M	1.02M	1.22M	1.50M	1.73M	2.38M	3.03M	3.24M	3.25M	4.20M	3.87M	0.03M	1.26M	2.42M	3.90M	4.29M	9.40M	7.41M
Gains from Sales and Divestitures (Quarter)									815.00	0.01M	9.91M	0.00M	0.01M	0.01M	0.01M		0.02M	0.15M	0.18M	0.03M
Gains from Investment Securities (Quarter)	2.54M	2.80M	0.26M	3.70M	3.95M	0.79M	1.47M	5.11M	1.34M	5.24M	0.04M	0.21M	5.63M	1.49M	0.23M	0.10M	9.35M	0.51M	-0.73M
Non-cash Items (Quarter)	47.44M	42.44M	19.38M	41.11M	31.63M	34.15M	82.49M	42.61M	29.92M	17.75M	49.73M	93.46M		0.01M	0.01M	0.28M	42.22M	29.30M	0.09M	0.08M
Cash from Operations (Quarter)	-4.00M	-6.53M	-13.09M	-5.66M	-8.88M	-9.72M	-14.87M	-11.42M	-14.94M	-15.61M	-14.80M	-23.67M		-6.80M	-22.61M	-18.76M	-20.14M	-22.10M	-33.69M	-24.10M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)																			0.61M	0.49M
Depreciation & Amortization (CF) (Quarter)	0.00M	0.00M	0.01M	0.01M	0.02M	0.02M	0.02M	0.02M	0.02M	0.03M	0.03M	0.03M	0.03M	0.22M	0.01M	0.00M	0.00M	0.01M	0.01M	0.01M
Change in Working Capital
Change in Account Payables (Quarter)	-0.20M	1.09M	-1.04M	1.59M	-0.71M	2.24M	-1.75M	2.12M	0.77M	-2.01M	-1.04M	0.83M	0.95M	0.30M	1.29M	2.68M	2.26M	-4.88M	0.30M	2.33M
Change in Accured Expenses (Quarter)	0.92M	-0.03M	0.03M	0.50M	-0.31M	1.44M	-1.77M	0.72M	-0.94M	0.11M	10.11M	0.39M	0.59M	0.24M	3.98M	-1.95M	4.81M	4.58M	-3.50M	5.77M
Investing Activities
Capital Expenditures (Quarter)		-0.01M	0.15M	0.09M	0.07M	-0.12M	0.16M	0.03M	0.02M	0.02M	0.08M					0.01M	0.01M	0.18M	0.00M
Change in Acquisitions & Divestments (Quarter)				12.52M	47.23M	30.25M	64.75M	31.00M	36.75M	34.75M	33.50M	23.58M	18.00M	21.00M	13.13M	12.85M				65.43M
Cash from Investing Activities (Quarter)		-0.06M	-113.34M	-20.40M	8.19M	4.64M	14.49M	15.38M	3.98M	-13.13M	5.65M	8.83M			13.13M	12.85M	-12.99M	-148.71M	-98.16M	-8.47M
Financing Activities
Other financing activities (Quarter)	1.01M						0.24M			0.07M		0.23M	0.07M	0.23M	3.00M	0.70M	189.75M		-1.34M	0.03M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)														95.00M	95.00M
Change in Capital Stock
Shares Issued (Quarter)			-0.25M			0.17M	-0.02M	0.22M	0.33M	-0.33M	0.76M	0.70M	-0.40M							0.04M
Preferred Shares Issued (Quarter)	55.53M
Misc.
Cash from Financing Activities (Quarter)	54.51M	128.31M	-0.25M			0.04M	0.36M	0.22M	45.29M	0.02M	0.46M	0.47M		94.77M	92.00M	-0.70M	191.31M		170.16M	-0.80M
Exchange Rate Effect (Quarter)																			-0.02M	-0.01M
Change in Cash (Quarter)	50.51M	121.73M	-126.68M	-26.06M	-0.68M	-5.04M	-0.02M	4.17M	34.33M	-28.72M	-8.69M	-14.37M		87.97M	69.39M	-19.46M	171.01M	-170.84M	38.33M	-33.35M
Free Cash Flow (Quarter)	-4.00M	-6.52M	-13.24M	-5.75M	-8.95M	-9.60M	-15.03M	-11.45M	-14.96M	-15.63M	-14.88M	-23.67M		-6.80M	-22.61M	-18.76M	-20.15M	-22.28M	-33.69M	-24.10M
Net Cash Flow (Quarter)	50.51M	121.73M	-126.68M	-26.06M	-0.68M	-5.04M	-0.02M	4.17M	34.33M	-28.72M	-8.69M	-14.37M		87.97M	82.52M	-6.61M	158.18M	-170.81M	38.31M	-33.37M

Research Tools

Jade Biosciences Cash Flow Statement (2020-2026) | JBIO

Create an account

Sign In

Reset Password